Alnylam Pharmaceuticals, Inc.

SILVERCREST ASSET MANAGEMENT GROUP LLC ALNY

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/17/2026

Shares

10,410

Value ($000)

4,140

Weight

0.0%

2024 Q4 - 2025 Q4 (5 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/17/2026	4,140	0.0%	10,410	12/31/2025
2025 Q3	11/14/2025	4,928	0.0%	10,807	9/30/2025
2025 Q2	8/14/2025	3,343	0.0%	10,251	6/30/2025
2025 Q1	5/15/2025	2,652	0.0%	9,821	3/31/2025
2024 Q4	2/14/2025	1,151	0.0%	4,891	12/31/2024